FDA Approves First Oral PCSK9 Drug for High Cholesterol
WASHINGTON, D.C. — The U.S. Food and Drug Administration approved Merck’s Lipfendra as the first oral PCSK9 inhibitor for adults with high cholesterol, introducing a once-daily alternative to injectable drugs …
FDA Approves First Oral PCSK9 Drug for High Cholesterol Read More